Terns Pharmaceuticals logo

Terns Pharmaceuticals Share Price (NASDAQ: TERN)

$6.96

-0.11

(-1.56%)

Last updated on

Check the interactive Terns Pharmaceuticals Stock chart to analyse performance

Terns Pharmaceuticals stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$6.79
    Today's High:$7.07

    Day's Volatility :3.96%

  • 52 Weeks Low:$1.87
    52 Weeks High:$11.40

    52 Weeks Volatility :83.64%

Terns Pharmaceuticals Stock Returns

PeriodTerns Pharmaceuticals IncSector (Health Care)Index (Russel 2000)
3 Months
112.04%
3.6%
0.0%
6 Months
105.16%
-7.7%
0.0%
1 Year
-3.8%
-12.6%
0.0%
3 Years
81.12%
9.5%
-4.7%

Terns Pharmaceuticals Inc Key Stats

Check Terns Pharmaceuticals key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$7.07
Open
$7.06
Today's High
$7.07
Today's Low
$6.79
Market Capitalization
$618.7M
Today's Volume
$912.1K
52 Week High
$11.4
52 Week Low
$1.865
Revenue TTM
$1000.0K
EBITDA
$-105.5M
Earnings Per Share (EPS)
$-1.03
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-35.02%

Stock Returns calculator for Terns Pharmaceuticals Stock including INR - Dollar returns

The Terns Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Terns Pharmaceuticals investment value today

Current value as on today

₹96,623

Returns

₹3,377

(-3.38%)

Returns from Terns Pharmaceuticals Stock

₹8,661 (-8.66%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Terns Pharmaceuticals Stock

-90%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Terns Pharmaceuticals Stock from India on INDmoney has decreased by -90% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Terns Pharmaceuticals Inc

  • Name

    Holdings %

  • Soleus Capital Management, L.P.

    9.34%

  • Orbimed Advisors, LLC

    8.65%

  • Deep Track Capital, LP

    8.57%

  • Morgan Stanley - Brokerage Accounts

    8.13%

  • Vivo Capital, LLC

    7.88%

  • BlackRock Inc

    6.52%

Analyst Recommendation on Terns Pharmaceuticals Stock

Rating
Trend

Buy

    78%Buy

    21%Hold

    0%Sell

Based on 14 Wall street analysts offering stock ratings for Terns Pharmaceuticals(by analysts ranked 0 to 5 stars)

Terns Pharmaceuticals Share Price Target

What analysts predicted

Upside of 187.36%

Target:

$20.00

Current:

$6.96

Terns Pharmaceuticals share price target is $20.00, a slight Upside of 187.36% compared to current price of $6.96 as per analysts' prediction.

Terns Pharmaceuticals Stock Insights

  • Price Movement

    In the last 3 months, TERN stock has moved up by 123.6%
  • TERN vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 78.6%
  • TERN vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 36.1%
  • Price to Sales

    ForTERN every $1 of sales, investors are willing to pay $198.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

Terns Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Terns Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Terns Pharmaceuticals Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Terns Pharmaceuticals Inc logo
19.3%
105.16%
-3.8%
81.12%
-62.18%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Terns Pharmaceuticals Inc

Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in Phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis (MASH); and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity, as well as TERN-800 series of small-molecule glucose-dependent insulinotropic polypeptide receptor (GIPR) modulators for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.
Organization
Terns Pharmaceuticals
Employees
59
CEO
Ms. Amy L. Burroughs M.B.A.
Industry
Services

Key Management of Terns Pharmaceuticals Inc

NameTitle
Ms. Amy L. Burroughs M.B.A.
CEO & Director
Ms. Melita Sun Jung
Chief Business Officer
Mr. Andrew W. Gengos
CFO & Head of Corporate Development
Ms. Caryn Gordon McDowell J.D.
Chief Legal Officer & Corporate Secretary
Ms. Robin Andrulevich
Chief People Officer
Dr. Jeffrey R. Jasper Ph.D.
Senior Vice President of Research
Dr. Emil T. Kuriakose M.D.
Chief Medical Officer
Mr. Scott Harris
Chief Development Officer
Ms. Debra Sieminski
Senior Vice President of Medical Affairs
Mr. James Kanter
Senior VP of CMC

Important FAQs about investing in TERN Stock from India :

What is Terns Pharmaceuticals share price today?

Terns Pharmaceuticals share price today is $6.96 as on at the close of the market. Terns Pharmaceuticals share today touched a day high of $7.07 and a low of $6.79.

What is the 52 week high and 52 week low for Terns Pharmaceuticals share?

Terns Pharmaceuticals share touched a 52 week high of $11.40 and a 52 week low of $1.87. Terns Pharmaceuticals stock price today i.e. is closed at $6.96, lower by 38.95% versus the 52 week high.

How to invest in Terns Pharmaceuticals Stock (TERN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Terns Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Terns Pharmaceuticals Shares that will get you 0.2155 shares as per Terns Pharmaceuticals share price of $6.96 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Terns Pharmaceuticals Stock (TERN) from India?

Indian investors can start investing in Terns Pharmaceuticals (TERN) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Terns Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Terns Pharmaceuticals share’s latest price of $6.96 as on August 30, 2025 at 1:29 am IST, you will get 1.4368 shares of Terns Pharmaceuticals. Learn more about fractional shares .

What are the returns that Terns Pharmaceuticals has given to Indian investors in the last 5 years?

Terns Pharmaceuticals stock has given -62.18% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?